GLP1R and diabetes mellitus: In the study by Maringwa et al. [44], the administration of GLP-1 receptor agonists in patients with diabetes and obesity could reduce systolic blood pressure by 2.8 mm Hg on average without any significant effect on diastolic blood pressure.